Evidence map›Paper›PMID 41194788›Full record

ArticleSurgical case reports2025

Hepatocellular Carcinoma Confined to the Bile Duct without Hepatic Mass or Jaundice: A Case Report.

Yuto Aoki, Masato Yoshioka, Yohei Kaneya, Kazuhiko Endo, Ryo Ga, Mampei Kawashima, Toshiyuki Irie, Junji Ueda, Tetsuya Shimizu, Youichi Kawano and 3 more

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuto AokiDepartment of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.
Masato YoshiokaDepartment of Gastroenterological Surgery, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan.
Yohei KaneyaYosei Clinic, Tokyo, Japan.
Kazuhiko EndoDepartment of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.
Ryo GaDepartment of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.
Mampei KawashimaDepartment of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.
Toshiyuki IrieDepartment of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.
Junji UedaDepartment of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.
Tetsuya ShimizuDepartment of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.
Youichi KawanoDepartment of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.
Yukio OshiroDepartment of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.
Yoshiharu NakamuraDepartment of Gastroenterological Surgery, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Chiba, Japan.
Hiroshi YoshidaDepartment of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHepatocellular carcinoma (HCC) presents as a hepatic mass and may involve vascular invasion or extrahepatic spread. However, intraductal growth within the intrahepatic bile duct is rare and is often associated with obstructive jaundice. HCCs confined to the intrahepatic bile duct without detectable hepatic mass or jaundice are rare, and diagnosis is often difficult due to clinical and radiological resemblance to perihilar cholangiocarcinoma. Moreover, such cases generally carry a poor prognosis. We report a rare case of HCC that developed exclusively within the intrahepatic bile ducts, without forming a detectable mass in the liver or causing jaundice. CASE PRESENTATION: A 70-year-old man presented with right hypochondriac pain. Imaging revealed dilation of the intrahepatic bile ducts in the anterior sector and intraductal filling defects, particularly in the intrahepatic bile duct branch of segment 8, without a detectable hepatic mass. Alpha-fetoprotein and Duke pancreatic monoclonal antigen type 2 levels were elevated, whereas prothrombin induced by vitamin K absence-II, carbohydrate antigen 19-9, and carcinoembryonic antigen levels were within normal limits. Perihilar cholangiocarcinoma was suspected based on imaging. Right hepatectomy with extrahepatic bile duct resection was performed after preoperative portal vein embolization. Intraoperative ultrasonography and gross examination revealed no parenchymal mass. Histopathology showed atypical hepatocyte-like cell clusters with pleomorphic nuclei proliferating within the Glisson's capsule and infiltrating the adjacent liver parenchyma in a trabecular pattern without fibrous capsule formation. Tumor infiltration into the bile duct epithelium was evident. Immunohistochemical staining was positive for HepPar1 and negative for cytokeratin 19, with a 40% Ki-67 labeling index, confirming HCC diagnosis. The patient remains recurrence-free at 2 years and 7 months postoperatively.

conclusionsThis case highlights a rare presentation of HCC without a hepatic mass or jaundice, confined to the intrahepatic bile duct. Most patients present with obstructive jaundice. Only two other English-language cases have no prior history of primary HCC, no hepatic mass, no jaundice, and disease confined to the bile duct. Although bile duct-invading HCC is generally associated with poor prognosis, our case suggests that early surgical intervention may lead to favorable long-term outcomes in select patients.

Indexed as

differential diagnosishepatectomyhepatocellular carcinomaintraductal growthintraductal tumor growthintrahepatic bile duct

Identifiers

PMID41194788
PMCPMC12583979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.